MSB 3.42% $1.21 mesoblast limited

banter and General Discussion, page-6745

  1. 4,195 Posts.
    lightbulb Created with Sketch. 5493
    Everything approved hypothetical...... I like this game.
    I'll comment on only GvHD and CLBP though as I've not looked into CHF or Crohns enough yet.

    Assumptions:
    SrAGvHD market penetration 40% ( Match JCR's 3 year figure ) 250 @ 550,000
    Adult SrAGvHD market penetration 40% ( Match JCR's 3 year figure ) 1500 @ 1,100,000
    CLBP market penetration 100% Of spinal fusion recipients - actual figure would include numbers who would not have done the spinal fusion also, but would only represent 1% of the total number of CLBP sufferers. 300,000 @ 30,000

    Total:

    $10,787,500,000.00 USD / ANNUM sales.
    50% profit ratio = 5,393,750,000.
    7:1 PE Market cap = $37,756,250,000
    Current market cap = $549,000,000 USD

    Gives a share prce of $70.83 AUD
    No crohns
    No CHF
    Nothing else
    No European market considered


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.21
Change
0.040(3.42%)
Mkt cap ! $1.381B
Open High Low Value Volume
$1.17 $1.22 $1.17 $5.683M 4.776M

Buyers (Bids)

No. Vol. Price($)
1 20000 $1.21
 

Sellers (Offers)

Price($) Vol. No.
$1.21 19746 3
View Market Depth
Last trade - 16.10pm 01/10/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.